📋 Structured Questions
Complete each question on paper, then check your answers against the mark scheme.
Question 1: Chiral Centres and Mirror Images
4 marksButan-2-ol exhibits optical isomerism.
(a) Draw 3D structures (using wedge/dash notation) of both enantiomers of butan-2-ol to show their relationship. [2]
(b) Identify the chiral carbon atom in butan-2-ol and explain why it is chiral. [2]
Show Mark Scheme
(a)
- Draw a central carbon atom with tetrahedral geometry (two bonds in the plane, one wedge pointing forward, one dash pointing away). [1]
- The second enantiomer must be drawn as a non-superimposable mirror image of the first across a vertical plane. [1]
(b)
- Carbon-2 (the second carbon atom in the chain). [1]
- It is chiral because it is bonded to four different groups: a hydrogen atom (-H), a hydroxide group (-OH), a methyl group (-CH3), and an ethyl group (-CH2CH3). [1]
Question 2: Planar Carbonyl Attack and Racemisation
5 marksEthanal reacts with hydrogen cyanide (HCN) to form 2-hydroxypropanenitrile.
(a) Name the mechanism for this reaction. [1]
(b) Explain, in terms of the geometry of the reactant, why the product is formed as a racemic mixture. [3]
(c) State the optical rotation of the resulting mixture. [1]
Show Mark Scheme
(a)
- Nucleophilic addition. [1]
(b)
- The carbonyl group (C=O) of ethanal (specifically the carbonyl carbon atom) has a planar geometry. [1]
- The nucleophile (:CN-) can attack the carbonyl carbon from either side of this plane (above or below). [1]
- There is an equal probability of attack from either side, which results in the formation of equal amounts (a 50:50 ratio) of both enantiomers (a racemic mixture). [1]
(c)
- 0 degrees / no rotation / optically inactive (the rotations of the two enantiomers cancel out). [1]
Question 3: Pharmaceutical Relevance
3 marksMany pharmaceutical drugs are chiral molecules. Explain why drugs are often synthesized or administered as a single enantiomer rather than a racemic mixture. Reference therapeutic effectiveness and side-effects. [3]
Show Mark Scheme
- Enantiomers have different shapes in 3D space. Receptors and enzymes in the body are chiral, so only one enantiomer will have the correct fit for the active site. [1]
- The other enantiomer is often therapeutically inactive. Administering a racemate would halve the dose efficiency. [1]
- More importantly, the inactive enantiomer may fit other receptors in the body, causing toxic or harmful side-effects (e.g. thalidomide, where one enantiomer cured morning sickness, while the other caused birth defects). [1]
⚡ Try Exam Mode
Timed, one-question-at-a-time practice with a full score breakdown. Pick topics and test yourself under real exam conditions.
Start Exam Mode